The FDA Law Blog
FEBRUARY 2, 2025
By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The rules were implemented to enhance patient safety protections via revised drug handling, packaging, and delivery requirements.
STAT
FEBRUARY 2, 2025
On Saturday, President Trump ordered import taxes on goods from Canada, China, and Mexico, a move that could raise costs for consumers across the economy, including in health care. Tariffs of 25% on imports from Canada (except energy) and Mexico, and 10% on goods from China take effect on Tuesday. Trump said the tariffs will remain in place until those countries stop the flow of fentanyl and undocumented immigrants into the United States.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
FEBRUARY 2, 2025
Medicare Advantage patients treated in value-based care models saw better outcomes than those treated in fee-for-service models, according to a new study from Optum.
pharmaphorum
FEBRUARY 2, 2025
Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
FEBRUARY 2, 2025
On Sunday, the National Science Foundation announced that its payment system was back online to comply with a judge’s order, five days after the agency froze funding to researchers. While post-doctoral fellows were relieved that they could now request the checks they rely on to pay for rent, food, and credit card bills, some remain concerned about what they see as contradictory messages that the funding agency has put out, and worry their grants and livelihoods may still be at risk.
pharmaphorum
FEBRUARY 2, 2025
Bavarian Nordic is likely just weeks away from bringing the second chikungunya vaccine to the EU, and the first approved for use in adolescents.
Expert insights. Personalized for you.
Let's personalize your content